Clinical Trial Update: Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of a combination of dronabinol and palmitoylethanolamide (PEA) for Tourette Syndrome has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Dronabinol (dronabinol)
• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: Yale University | Conditions: Tourette Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-12-19